The need for therapies that can repair or prevent damage for the millions of people worldwide living with neurodegenerative diseases like Alzheimer’s, Parkinson’s, and ALS is immense. Researchers at the U-M College of Pharmacy are developing a promising new approach to treatment that focuses on overcoming the blood–brain barrier, which often prevents therapeutic doses of drugs from reaching the brain. Read more from the College of Pharmacy about this work.
